Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant human PTH vs Forteo for osteoporosis
IRCT138810121414N5Phase 3Completed
- Sponsor
- CinnaGen
- Start
- Feb 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of teriparatide in osteoporosis (2 arms), sponsored by CinnaGen. Primary endpoint: Change in bone mineral density. Started Feb 2011; status: completed.
02
Drugs
teriparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on IRCT138810121414N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138810121414N5.